Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) — Cash Flow Reinvestment Rate
Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) has a Cash Flow Reinvestment Rate of 1.37x as of December 2024, reinvesting CN¥140.48 Million (capex CN¥83.91 Million plus investments CN¥-56.57 Million) from operating cash flow of CN¥102.67 Million. Explore Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Xinxiang Tuoxin Pharmaceutical Co.Ltd. Cash Flow Reinvestment Rate (2019–2024)
Historical reinvestment intensity for Xinxiang Tuoxin Pharmaceutical Co.Ltd. across 6 annual periods. Also explore Xinxiang Tuoxin Pharmaceutical Co.Ltd. asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Xinxiang Tuoxin Pharmaceutical Co.Ltd. (2019–2024)
Year-by-year capital reinvestment analysis for Xinxiang Tuoxin Pharmaceutical Co.Ltd.. For live market cap and broader valuation context, see Xinxiang Tuoxin Pharmaceutical Co.Ltd. (301089) total market value.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.37x | CN¥140.48 Million | CN¥102.67 Million | CN¥83.91 Million | ▼ -84.7% |
| 2023 | 8.97x | CN¥241.79 Million | CN¥26.95 Million | CN¥185.22 Million | ▲ +676.1% |
| 2022 | 1.16x | CN¥310.74 Million | CN¥268.85 Million | CN¥148.33 Million | ▼ -84.6% |
| 2021 | 7.48x | CN¥435.46 Million | CN¥58.19 Million | CN¥112.73 Million | ▲ +508.7% |
| 2020 | 1.23x | CN¥147.51 Million | CN¥120.00 Million | CN¥74.12 Million | ▼ -32.1% |
| 2019 | 1.81x | CN¥156.36 Million | CN¥86.38 Million | CN¥76.20 Million | — |